Drug-coated balloons (DCB)

News

News: BD Announces Clinical Trial Data for the Lutonix 014 Drug-Coated Balloon Below-The-Knee IDE Trial

11/27/2018

Safety and efficacy results presented during late-breaking clinical trials session at VIVA 2018.

Safety and efficacy results...

11/27/2018

Cath Lab Digest

New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital

11/27/2018

Cath Lab Digest talks with Ian M. Cawich, MD, Arkansas Heart Hospital, Little Rock, Arkansas.

Cath Lab Digest talks with Ian M. Caw...

The newest device that we have been able to use has been the 220 mm length version of the Lutonix 035 drug-coated balloon (BD/Bard). We have used this product since it launched in August and have done six cases thus far, all with great...

The newest device that we have...

11/27/2018

Cath Lab Digest

Clinical News

News: C.R. Bard Receives FDA Premarket Approval of the Lutonix 035 Drug-Coated Balloon as the First and Only DCB for the Treatment of Patients with Dysfunctional AV Fistulae

10/01/2017

New Option to Preserve Vascular Access and Help Hemodialysis Patients Extend Time Between Reinterventions

New Option to Preserve Vascular...

10/01/2017

Cath Lab Digest

A Real-World Comparison of IN.PACT vs Lutonix Drug-Coated Balloons in Complex Lesions

03/03/2016

Cath Lab Digest talks with Sabine Steiner, MD, MSc
Department of Interventional Angiology, Medical University Leipzig, Germany.

Cath Lab Digest talks with Sabine Ste...

Our study included 281 patients undergoing treatment with the IN.PACT drug-coated in 366 limbs. We also have about 137 patients treated with the Lutonix drug-coated balloon in 168 limbs.

Our study included 281 patients...

03/03/2016

Cath Lab Digest

Technology Pulse

The Drug-Coated Balloon: Not Just a Balloon

11/05/2014

J.A. Mustapha, MD, Larry J. Diaz-Sandoval, MD, Fadi Saab, MD, Metro Health Hospital, Wyoming, Michigan

J.A. Mustapha, MD, Larry J. Diaz-Sand...

The DCB represents a technology that is able to carry and deliver an anti-proliferative drug to the arterial wall at the same time the mechanical treatment is provided to the obstructive atherosclerotic plaque. Understanding this apparently...

The DCB represents a technology...

11/05/2014

Cath Lab Digest